Volume | 48,964 |
|
|||||
News | - | ||||||
Day High | 1.19 | Low High |
|||||
Day Low | 1.12 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Hoth Therapeutics Inc | HOTH | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.19 | 1.12 | 1.19 | 1.16 | 1.17 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
265 | 48,964 | US$ 1.17 | US$ 57,232 | - | 0.99 - 4.30 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
17:37:34 | formt | 100 | US$ 1.25 | USD |
Hoth Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
5.04M | 4.35M | - | 0 | -7.85M | -1.80 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Hoth Therapeutics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HOTH Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.18 | 1.23 | 1.10 | 1.18 | 24,493 | 0.07 | 5.93% |
1 Month | 1.48 | 1.49 | 1.10 | 1.33 | 61,091 | -0.23 | -15.54% |
3 Months | 1.32 | 1.67 | 1.10 | 1.37 | 475,839 | -0.07 | -5.30% |
6 Months | 1.41 | 1.73 | 0.99 | 1.39 | 357,905 | -0.16 | -11.35% |
1 Year | 2.28 | 4.30 | 0.99 | 2.64 | 694,928 | -1.03 | -45.18% |
3 Years | 38.50 | 55.00 | 0.99 | 21.21 | 1,347,787 | -37.25 | -96.75% |
5 Years | 131.00 | 226.75 | 0.99 | 34.88 | 1,227,642 | -129.75 | -99.05% |
Hoth Therapeutics Description
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups. |